Bluesight
Bluesight did not start with a grand speech about transforming healthcare. It started in 2011 with Kevin MacDonald staring at a problem that felt almost too operational to matter, until you realize it touches every patient, every shift, every hospital balance sheet. Medication tracking was manual, messy, and quietly expensive in all the ways that never show up clean on a dashboard. So Kevin MacDonald built Kit Check, bootstrapped it through the first 16 hospital customers, and proved something most founders only talk about. If the workflow is real, the market will meet you there.
That early signal turned into $22M in venture backing and a steady climb into hundreds of hospitals and millions of medications tracked. Then came the shift. Kit Check became Bluesight, and the product grew up. Not louder, not flashier, just deeper. What began as automation moved into something more strategic, a layer they now call Medication Intelligence. Not a tagline, a position. When you sit inside the medication lifecycle, inventory, diversion, procurement, privacy, you are not a feature. You are infrastructure.
Today Bluesight supports more than 3,000 hospitals across the United States and Canada, with Kevin MacDonald still leading as Co Founder and CEO, alongside Mark Peters as CFO and Vijay Venkatesh as CTO. The platform now spans ControlCheck for drug diversion monitoring and PrivacyPro for patient privacy analytics, the latter strengthened by the 2025 acquisition of Protenus. That move was not expansion for the sake of growth. It was alignment. Medication and data share the same risk surface, and Bluesight decided to own both.
The market is not subtle about needing this. Hospitals are squeezed on margins, short on staff, and under a microscope when something goes wrong. Diversion and privacy incidents do not stay internal anymore. They travel. Bluesight sits in that tension and translates it into workflows that teams can actually act on, not just alerts that pile up like unread emails.
Recognition tends to follow consistency, and in 2026 Bluesight’s ControlCheck and PrivacyPro each earned Best in KLAS in their respective categories, marking repeated wins that say more about endurance than hype. This is what it looks like when a company compounds trust over time.
Bluesight is hiring across engineering, product, and operations for people who understand that high stakes systems require calm thinking and precise execution. If you are building in healthcare data, compliance, or AI driven infrastructure, this is a company worth watching closely, or working with directly, because the layer they are building is not optional anymore, it is becoming expected.